Advanced Technology Partnerships and Initiatives
The National Cancer Institute (NCI) established the Advanced Technology Partnerships Initiative (ATPI) in 2008, in response to a nationally recognized need to improve drug development processes and success rates, through enhanced collaboration among government, academia, life sciences companies, and non-profit research organizations.
This includes building cross-disciplinary collaborations and teams, bridging the gap between late discovery and early development of diagnostics and therapeutics, developing cross-cutting technology platforms, and developing data standards. The overarching goal is to accelerate treatments for cancer and AIDS patients. The ATPI has established numerous partnerships to date.
Many ATPI partnerships projects will be accomplished at Frederick National Laboratory for Cancer Research (FNLCR), a Federally Funded Research and Development Center (FFRDC) in Frederick, Md. – a government-owned, contractor-operated laboratory dedicated to biomedical research and development. Opportunities exist to co-locate partnership projects at the Advanced Technology Research Facility (ATRF), beginning in mid-2012 (read more).
FNLCR, has a wide range of advanced technologies and innovative platforms that support NCI’s mission, from basic research to translational and clinical studies. These include:
| Cancer Model Development Genetics and Genomics Proteins and Proteomics Clinical Assay Development |
Nanotechnology Characterization High-Performance Biomedical Computing Advanced Biomedical Imaging |
For more information please contact:
| David Hoekzema (Contractor) Vice President, Business Development Director, Advanced Technology Partnerships Initiative SAIC-Frederick, Inc. 301-846-5895 hoekzemadt@mail.nih.gov |
